[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Oral Presentations - OP0126 A phase 2 study of safety and efficacy of anabasum (JBT-101) in systemic sclerosis
Spiera, R, Hummers, L, Chung, L, Frech, T, Domsic, R, Furst, D, Gordon, J, Mayes, M, Simms, R, Constantine, S, White, BLanguage:
english
DOI:
10.1136/annrheumdis-2017-eular.2712
File:
PDF, 161 KB
english